Accuray Inc.'s bid to acquire TomoTherapy Inc. would bring together two companies with complementary radiation-based treatments for cancer. [See Deal] The deal – valued at $277 million – would also combine two of the 11 medical device companies that succeeded in going public in 2007, the last year the sector had a respectable chance to go public. [See Deal][See Deal]
The merits of the Accuray-TomoTherapy deal will be weighed by shareholders on both sides. But a review of those 11 companies shows their performance is decidedly mixed. Only five of...